APA (7th ed.) Citation

H, J., L, A., A, W., J, E., EH, C., ES, B., . . . J, K. (2022). The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT- and rTg(P301L)4510 mouse models of Alzheimer's disease. Alzheimer's & dementia (New York, N. Y.), 8(1), e12247. https://doi.org/10.1002/trc2.12247

Chicago Style (17th ed.) Citation

H, Jimenez, Adrien L, Wolin A, Eun J, Chang EH, Burstein ES, Gomar J, Davies P, and Koppel J. "The Impact of Pimavanserin on Psychotic Phenotypes and Tau Phosphorylation in the P301L/COMT- and RTg(P301L)4510 Mouse Models of Alzheimer's Disease." Alzheimer's & Dementia (New York, N. Y.) 8, no. 1 (2022): e12247. https://doi.org/10.1002/trc2.12247.

MLA (9th ed.) Citation

H, Jimenez, et al. "The Impact of Pimavanserin on Psychotic Phenotypes and Tau Phosphorylation in the P301L/COMT- and RTg(P301L)4510 Mouse Models of Alzheimer's Disease." Alzheimer's & Dementia (New York, N. Y.), vol. 8, no. 1, 2022, p. e12247, https://doi.org/10.1002/trc2.12247.